Home
Conditions
Recurrence

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,312 public trials 521 recruiting studies

Refine in advanced search Browse all conditions

Recurrence trial results

Completed

NMP in Relapsed / Refractory Myeloma

NCT02468687

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations: Peter MacCallum Cancer Centre Melbourne, Victoria, Australia

View Trial Details

Completed

Trial to Find and Investigate a Safe Dose of F16IL2 and BI 836858 in Patients With AML Relapse After Allogeneic Hematopoietic Stem Cell Transplantation

NCT03207191

Conditions: Acute Myeloid Leukemia (AML) Relapse, Disease Attributes, Hematologic Diseases, +9 more
Locations: University Medical Center Freiburg Freiburg im Breisgau, Germany

Münster University Hospital Münster, Germany

View Trial Details

Completed

Sintilimab in Combination With Chidamide in Refractory and Relapsed ENKTCL

NCT03820596

Conditions: Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
Locations: Department of hematology department, Nanfang hospital Guangzhou, Guangdong, China

Guangdong General Hospital; Guangdong Provincial People's Hospital Guangzhou, Guangdong, China

Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology Wuhan, Hubei, China

Sun Yat-sen University Cancer Center Guangzhou, China

View Trial Details

Completed

Immunotherapy Study for Metastatic Renal Cell Cancer

NCT02035358

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +24 more
Locations: University of Iowa Hospitals and Clinics Iowa City, Iowa, United States

John Hopkins University Baltimore, Maryland, United States

Univeristy of Utah Salt Lake City, Utah, United States

View Trial Details

Completed

Preoperative Bevacizumab Injection in Primary Pterygium in Tunisian Patients

NCT05314673

Conditions: Conjunctival Diseases, Disease Attributes, Eye Diseases, +4 more
Locations: Dhouha Gouider Aryanah, Illinois, Tunisia

View Trial Details

Completed

Comparison of Hernia Sac Ligation Versus Invagination

NCT05308251

Conditions: Digestive System Diseases, Disease Attributes, Gastrointestinal Diseases, +16 more
Locations: Samsun Eğitim ve Araştırma Hastanesi Samsun, Turkey (Türkiye)

View Trial Details

Completed

AC220 for Children With Relapsed/Refractory ALL or AML

NCT01411267

Conditions: Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +15 more
Locations: Childrens Hospital Los Angeles Los Angeles, California, United States

Children's Hospital Central California Madera, California, United States

UCSF School of Medicine San Francisco, California, United States

The Children's Hospital, University of Colorado Aurora, Colorado, United States

View Trial Details

Completed

Flaxseed as Maintenance Therapy for Ovarian Cancer Patients in Remission

NCT02324439

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +25 more
Locations: Southern Illinois University School of Medicine Springfield, Illinois, United States

View Trial Details

Completed

Interest of Fluorescence in Salvage Surgery for Recurrence of Head and Neck Cancer in Irradiated Area

NCT02920216

Conditions: Disease Attributes, Head and Neck Cancer, Head and Neck Neoplasms, +5 more
Locations: Institut de Cancérologie de Lorraine Vandœuvre-lès-Nancy, France

View Trial Details

Completed

MEDI2228 in Subjects With Relapsed/Refractory Multiple Myeloma

NCT03489525

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations: Research Site Phoenix, Arizona, United States

Research Site Jacksonville, Florida, United States

Research Site Boston, Massachusetts, United States

Research Site Boston, Massachusetts, United States

View Trial Details

Recurrence

Recurrence trial results

Related conditions